SELLAS Life Sciences (SLS) earnings, Nov 12, 2026: EPS +17%, stock −4.6%
In brief
SELLAS Life Sciences reported on Nov 12, 2026. Earnings per share changed +17% year over year, 0.0% above the estimate; revenue 0%. The stock opened with a −3.1% gap and closed the day −4.6% (Nov 12, 2026). The stock is now 49.4% below its 52-week high, +438.9% over 12 months. Next report: Mar 25, 2027.
EPS vs estimate0.0%
EPS, YoY+17%
Revenue, YoY0%
Gap · day−3.1% · −4.6%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 12, 2026 | +21.1% | +25.1% |
| Aug 11, 2026 | +7.9% | +6.5% |
| Nov 12, 2026 | −3.1% | −4.6% |
Next-quarter estimates, ratings and the SLS chart are in the terminal.
Open the terminalFAQ
When is SELLAS Life Sciences's next earnings report?
Mar 25, 2027. The date comes from daily data and is corrected if the company moves it.
How did SELLAS Life Sciences stock react to the report?
Opening gap −3.1%, day's result −4.6%.
Did SELLAS Life Sciences's earnings grow?
Earnings per share rose 17% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.